Innovative Research Award

Ankana Daga is a researcher affiliated with Boston Children’s Hospital and Harvard Medical School whose scholarly work has contributed significantly to the fields of nephrology, genomics, precision medicine, and rare kidney disease research. Her academic publications demonstrate consistent engagement with whole-exome sequencing methodologies, monogenic kidney disorders, and translational biomedical science. The research profile associated with her scholarly record reflects a sustained contribution to clinical genetics and pediatric nephrology research through collaborative and multidisciplinary investigation.[1]

Abstract

This academic recognition article presents an overview of the scientific contributions and research profile of Ankana Daga within the fields of medical genetics, nephrology, and precision medicine. The profile is characterized by high-impact publications related to whole-exome sequencing, congenital kidney disorders, nephrotic syndrome, and molecular diagnostics. The research demonstrates a strong emphasis on genomic methodologies and translational applications in clinical medicine. With an established citation record and an h-index indicative of sustained scholarly influence, the researcher’s contributions align with the objectives of the Global Innovation Technologist Awards in recognizing scientific advancement and innovation in healthcare research.[2]

Keywords

• Precision medicine
• Whole-exome sequencing
• Nephrology
• Clinical genomics
• Rare kidney disease

Introduction

Contemporary biomedical research increasingly relies on genomic technologies to improve diagnostic precision and therapeutic decision-making. Within this evolving landscape, researchers working at the intersection of nephrology and molecular genetics have contributed substantially to the understanding of hereditary kidney disorders. Ankana Daga’s research portfolio reflects engagement with this interdisciplinary framework through publications focusing on monogenic diseases, nephrotic syndromes, and congenital anomalies affecting renal development.[3]

The researcher’s scholarly contributions have frequently involved collaborative investigations published in internationally recognized journals, including Nature Genetics, Kidney International, and the Journal of the American Society of Nephrology. These publications demonstrate the practical application of genomic sequencing technologies to pediatric and adult nephrology research while also supporting the broader advancement of precision medicine approaches in healthcare.[4]

Research Profile

According to the available academic metrics, Ankana Daga has authored or co-authored 35 indexed scholarly documents and accumulated approximately 1,820 citations, with an h-index of 21. These metrics indicate sustained engagement with high-impact biomedical research and a measurable influence within the scientific community.[1]

The research profile is strongly associated with studies involving genomic diagnostics and kidney disease genetics. Many of the publications focus on the implementation of whole-exome sequencing in identifying causative mutations responsible for nephrotic syndrome, nephrolithiasis, nephrocalcinosis, and congenital anomalies of the kidney and urinary tract. The interdisciplinary nature of the research further highlights integration between molecular biology, clinical nephrology, and translational medicine.[5]

Research Contributions

One of the notable contributions associated with the researcher includes investigations into steroid-resistant nephrotic syndrome using whole-exome sequencing methodologies. Such studies have improved understanding of genetic variants associated with complex kidney disorders and facilitated more accurate clinical characterization of affected patients.[6]

Additional research contributions involve the identification of mutations in KEOPS-complex genes and nuclear pore complex components linked to nephrotic syndrome and microcephaly. These findings contributed to expanding the understanding of molecular pathways involved in renal disease pathogenesis and rare developmental disorders.[7]

The researcher has also participated in studies demonstrating the utility of whole-exome sequencing in precision medicine approaches for kidney transplant recipients. This work highlights the clinical importance of genomic diagnostics in informing treatment decisions and improving patient-specific therapeutic strategies.[8]

• Application of genomic sequencing in nephrology research
• Investigation of hereditary kidney diseases
• Development of precision medicine strategies
• Clinical translational research in pediatric nephrology
• Collaborative interdisciplinary biomedical research

Publications

1. Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clinical Journal of the American Society of Nephrology, 2018.
2. Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nature Genetics, 2017.
3. Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract. Journal of the American Society of Nephrology, 2018.
4. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney International, 2018.
5. Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. Journal of the American Society of Nephrology, 2019.

Research Impact

The research impact associated with Ankana Daga is reflected through both citation metrics and the clinical relevance of the published work. Publications linked to genomic sequencing and nephrology have contributed to advancements in disease diagnosis, clinical classification, and precision treatment strategies. Citation activity exceeding 1,800 citations indicates broad scholarly engagement with the research findings across multiple biomedical disciplines.[1]

Several publications have been recognized within high-impact journals, demonstrating the significance of the research within international scientific communities. The integration of genomic technologies into patient-centered nephrology research has further supported translational applications that bridge laboratory investigation with clinical practice.[4]

Award Suitability

The Global Innovation Technologist Awards recognize individuals whose work demonstrates innovation, scientific advancement, and measurable research impact. Based on the available academic indicators and publication record, Ankana Daga’s research profile aligns with several of these objectives through contributions to precision medicine, genomic diagnostics, and translational nephrology research.[9]

The combination of interdisciplinary collaboration, publication quality, citation influence, and clinical relevance supports the suitability of the researcher for recognition within international scientific award frameworks. The researcher’s scholarly contributions continue to support advancements in medical genetics and kidney disease diagnostics within the broader biomedical research community.[5]

Conclusion

Ankana Daga’s academic profile demonstrates sustained contributions to the advancement of genomic medicine and nephrology research. Through collaborative investigations, high-impact publications, and translational clinical applications, the researcher has contributed to improving understanding of hereditary kidney disorders and precision medicine methodologies. The scholarly record, citation performance, and research relevance collectively position the researcher as a noteworthy contributor within contemporary biomedical science.[1]

External Links

• Scopus Author Profile
  
• Google Scholar Profile

References

1. Elsevier. (n.d.). Scopus author details: Ankana Daga, Author ID 55893187400. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=55893187400
   
2. Google Scholar. (n.d.). Academic citation profile of Ankana Daga.
   https://scholar.google.com/citations?user=TVK8miwAAAAJ
   
3. Warejko JK, Tan W, Daga A, et al. (2018). Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clinical Journal of the American Society of Nephrology.
   https://doi.org/10.2215/CJN.04120417
   
4. Braun DA, Rao J, Mollet G, Daga A, et al. (2017). Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nature Genetics.
   https://doi.org/10.1038/ng.3933
   
5. Van Der Ven AT, Connaughton DM, Ityel H, Daga A, et al. (2018). Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract. Journal of the American Society of Nephrology.
   https://doi.org/10.1681/ASN.2017121265
   
6. Daga A, Majmundar AJ, Braun DA, et al. (2018). Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney International.
   https://www.sciencedirect.com/science/article/pii/S0085253817304945
7. Braun DA, Lovric S, Daga A, et al. (2018). Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome. The Journal of Clinical Investigation.
   https://doi.org/10.1172/JCI98688
   
8. Mann N, Braun DA, Daga A, et al. (2019). Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. Journal of the American Society of Nephrology.
   https://doi.org/10.1681/ASN.2018060575
   
9. Global Innovation Technologist Awards. (n.d.). Official award platform and recognition program information.
   innovationtechnologist.com